<DOC>
	<DOC>NCT02119845</DOC>
	<brief_summary>The primary objective of this clinical study is to evaluate the preliminary safety and effectiveness of using the FLEX-1 device for the creation of an arteriovenous fistula (AVF) in patients requiring chronic hemodialysis.</brief_summary>
	<brief_title>A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>Eligible for a native surgical arteriovenous fistula, as determined by the treating physician. Adult (age &gt;18 years old). Advanced chronic kidney disease (CKD), stage 4 or 5 electing for hemodialysis. Written informed consent obtained</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Arteriovenous fistula (AVF)</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Vascular access</keyword>
	<keyword>Endovascular AVF (EndoAVF)</keyword>
</DOC>